Clinical Trial Update: Insulin Glargine Combination Therapies in Type II Diabetics [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating insulin glargine combination therapies in Type 2 diabetes has completed. The document reports the study status as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED